Thornburg Investment Management Inc. Trims Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Thornburg Investment Management Inc. lessened its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 4.3% in the first quarter, HoldingsChannel reports. The firm owned 120,706 shares of the company’s stock after selling 5,370 shares during the quarter. Thornburg Investment Management Inc.’s holdings in Acadia Healthcare were worth $9,546,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in shares of Acadia Healthcare by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock worth $689,065,000 after purchasing an additional 30,296 shares during the period. Avidity Partners Management LP increased its stake in Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after purchasing an additional 441,692 shares during the last quarter. Jennison Associates LLC lifted its position in Acadia Healthcare by 26.1% during the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock worth $89,327,000 after buying an additional 238,114 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Acadia Healthcare by 3.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,035,114 shares of the company’s stock worth $80,490,000 after buying an additional 38,410 shares during the last quarter. Finally, Iron Triangle Partners LP grew its holdings in Acadia Healthcare by 3.5% in the 4th quarter. Iron Triangle Partners LP now owns 791,993 shares of the company’s stock valued at $61,585,000 after buying an additional 26,789 shares during the period.

Acadia Healthcare Stock Up 1.0 %

NASDAQ ACHC traded up $0.63 during trading hours on Wednesday, hitting $66.28. The company had a trading volume of 2,072,221 shares, compared to its average volume of 736,537. The firm’s 50 day moving average is $66.90 and its 200 day moving average is $74.45. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. Acadia Healthcare Company, Inc. has a fifty-two week low of $62.04 and a fifty-two week high of $87.77. The company has a market capitalization of $6.15 billion, a price-to-earnings ratio of -473.39, a P/E/G ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The company’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.75 earnings per share. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.52 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ACHC has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a research report on Thursday, April 25th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, July 9th. Mizuho reduced their target price on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. Finally, StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, May 21st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $87.56.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.